{"id":3021,"date":"2024-11-26T10:41:50","date_gmt":"2024-11-26T10:41:50","guid":{"rendered":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/?p=3021"},"modified":"2024-11-26T10:42:22","modified_gmt":"2024-11-26T10:42:22","slug":"centre-for-trials-research-at-ictmc2024-7th-international-clinical-trials-methodology-conference-ictmc","status":"publish","type":"post","link":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/centre-for-trials-research-at-ictmc2024-7th-international-clinical-trials-methodology-conference-ictmc\/","title":{"rendered":"Centre for Trials Research At #ICTMC2024: 7th International Clinical Trials Methodology Conference (ICTMC)"},"content":{"rendered":"

– Helen Stanton, Waku Maboshe and Fiona Lugg-Widger<\/p>\n

This year, the bi-annual International Clinical Trials Methodology Conference (ICTMC) was held in the beautiful and historic city of Edinburgh, Scotland. Held at Edinburgh\u2019s International Conference Centre, proceedings took place from the 30th<\/sup> of September to the 3rd <\/sup>of October 2024. The program included presentations and posters, bookended by educational workshops on Monday morning and afternoon and Thursday afternoon. This structure allowed attendees to engage deeply with educational content before and after the main conference events.<\/p>\n

The ICTMC meeting is an ideal space for sharing much in the way of clinical trials methodologies and offers a valuable opportunity for in-person networking and collaboration, which feels like a novelty these days!<\/p>\n

This year\u2019s event welcomed 1,300 delegates (an increase of 400 since ICTMC 2022!). If seemingly large conferences are not your thing, please don\u2019t let the number of attendees put you off. Whether a student or a seasoned triallist, ICTMC provides an ideal opportunity to connect with colleagues, team members and potential collaborators over a poster or two. Although this is not to underestimate the platform for dissemination the conference provides; this is an occasion to survey the progress and innovation of clinical trial research and get to understand the systems by which these advancements have come about.<\/p>\n

The Centre for Trials Research (CTR) delegation was 22 people strong this year, comprising divisional and study leads, statisticians, routine data researchers, qualitative researchers, research nurses, trial managers, and data managers. Oral presentations by CTR attendees were popular and exceptionally well received. Similarly, poster presentations attracted a great deal of interest, with fellow attendees stopping to chat with colleagues about their work.<\/p>\n

\"Fiona
Fiona Lugg-Widger \u2013 oral presentation prize-winner<\/figcaption><\/figure>\n

A special shout-out goes to Fiona Lugg Widger, who won the “Excellence in Involving Patients and Public in Trials Methods Research” prize for her incredibly well-received presentation with research partner, Mike Molete, on public-informed research training. This recognition highlights the impactful work being done in making research more inclusive and community-centric.<\/p>\n

Of course, not to be forgotten, Rob Trubey\u2019s educational workshop was very well attended, necessitating additional chairs being brought in! Further descriptions of CTR contributions to the conference are included below.<\/p>\n

Daily plenary sessions at the event provided a fantastic opportunity to hear world-leading experts share their experiences and expertise on the design and conduct of clinical trials:<\/p>\n

Prof. Linda Collins opened the conference on Tuesday morning with her keynote, titled \u201cAchieving intervention EASE <\/em>with the multiphase optimization strategy (MOST)\u201d, in which she introduced an alternative paradigm for developing, optimizing, and evaluating behavioural and bio-behavioural interventions.<\/p>\n

Wednesday afternoon Professor Deborah Ashby gave the Prof. Doug Altman Memorial Lecture on \u201cBayesian Approaches to Randomised Trials: Celebrating the Past 30 Years, Looking Forward to the Future\u201d.<\/p>\n

Prof Kamlesh Khunti delivered Thursday\u2019s keynote on \u201cEthnic minority representation in clinical trials\u201d. His session brought together the clinical importance of inclusivity in trials as well as the wider societal importance, and the resources we can utilise to help us do better including enhancing quality in data. His publication he referred to in his presentation was published the next day (https:\/\/doi.org\/10.5281\/zenodo.13890529<\/a>).<\/p>\n

Further education and training opportunities were offered through pre- and post-conference workshops hosted by expert delegates. These included sessions on a diverse range of topics around trial methodology and conduct. A special mention to CTR\u2019s Rob Trubey who led a very well-attended workshop titled \u201cCan Healthcare Systems Data be relied upon for measuring clinical trial outcomes? An updated perspective\u201d.<\/p>\n

Conference Highlights<\/strong><\/h2>\n
\"\"<\/figure>\n

Exploring Edinburgh: A City Steeped in History and Modernity<\/strong><\/h2>\n

Edinburgh is a beautiful city to explore on foot, offering a vibrant mix of historic charm with its iconic sandstone buildings and modern attractions, including a dynamic cultural scene and gastronomy. Some attendees arrived early and made the most of their downtime by visiting the botanical gardens, exploring Edinburgh Castle, and sampling cuisine from its burgeoning food scene.<\/p>\n

\"\"<\/figure>\n

A Night at the Museum<\/strong><\/h2>\n

The Victorian architecture of the National Museum of Scotland provided a spectacular backdrop for the conference party. Held within the grand gallery, delegates were welcomed by a bagpiper and enjoyed fantastic entertainment, featuring a lively ceilidh and an electric live band playing party tunes. The event also offered the chance to visit exhibitions and savour delicious, ethically sourced Scottish produce, including haggis with a vegan option.<\/p>\n

Impact on Our Day-to-Day Work<\/strong><\/h2>\n

The conference played a crucial role in enhancing our everyday work by increasing confidence with the latest methodological developments and trends. Being at the conference allowed us to converse and learn firsthand from those actively engaged in this work, gaining insights from their experiences with the triumphs and setbacks of new methodologies. This direct interaction is a key benefit, enabling us to confidently incorporate new advances into our practices and improve the quality and impact of our research.<\/p>\n

Cultural Shift in Research Conduct and Methodology<\/strong><\/h2>\n

It\u2019s inspiring to see how far public involvement in trials has progressed since the late 2010s. This cultural shift is now well-established, evident in the numerous posters and presentations employing these methods as well as the large number of public members attending and contributing throughout the conference. The focus on underserved populations and maximising inclusivity in co-designing and participating in research, such as Vicky Shepherd\u2019s work, further underscores this transformation (see more on Vicky\u2019s session in the oral presentations section below).<\/p>\n

\"Museum\"<\/figure>\n

Oral presentations<\/strong><\/h2>\n

There was strong representation from CTR at the parallel presentation sessions. The diverse range of talks on offer left attendees spoilt for choice. There truly was something to suit everyone\u2019s areas of interest. Below is a brief description of the talks presented by CTR researchers:<\/p>\n

In a change to the traditional conference presentation format, Martina Svobodova was invited on Tuesday morning to give a lightning talk on \u201cPatient and Public Involvement in the Design and Protocol Development for a Platform Randomised Trial to Evaluate Diagnostic Tests to Optimise Antimicrobial Therapy\u201d. This short-form talk was about co-production in the development of the PROTECT trial.<\/p>\n

\"Fiona
Fiona Lugg-Widger and Mike Molete presenting at ICTMC 2024<\/figcaption><\/figure>\n

That afternoon saw Mike Molete from the Transforming Data For Trials Public Advisory Group, and Fiona Lugg-Widger co-presenting \u201cPublic-informed training: Working with public contributors on trial methods”. The content and delivery of this presentation were a fantastic demonstration of public involvement in trial methods co-production.<\/p>\n

Vicky Shepherd opened Wednesday morning\u2019s SWAT parallel session with her presentation on the \u201cFeasibility of conducting a \u2018Study Within a Trial\u2019 of a recruitment intervention for trials involving adults with impaired capacity to consent (CONSULT SWAT)\u201d. The talk aimed to discuss the achievability of conducting a SWAT within CONSULT; a project designed to evaluate a decision-support intervention to help consultees and legal representatives of adults lacking the capacity to consent to take part in research.<\/p>\n

Lawrence Raisanen delivered \u201cAuto-coding MedDRA: Comparing NLP Fuzzy Matching and Manual Encoding of Free-text Adverse Events in a Cancer Trial\u201d in the afternoon\u2019s \u2018parallel session on \u2018Electronic health records and machine learning\u2019. Lawrence discussed how auto-coding free-text safety data can offer a faster, less resource-heavy alternative to manual free-text coding methods.<\/p>\n

\"Nigel
Nigel Kirby and Phoebe Dawe presenting at ICTMC 2024<\/figcaption><\/figure>\n

In the Wednesday afternoon parallel session on \u2018Information Systems and technology\u2019 Nigel Kirby and Phoebe Dawe from the University of Exeter co-presented \u201cConsolidating Data Management and IS Knowledge\u201d. This talk was about the GW4 collaboration, a cross-institutional collaboration which examines how CTR and other clinical trial units \u2018do\u2019 data management.<\/p>\n

\"Phil
Phil Pallman presenting at ICTMC 2024<\/figcaption><\/figure>\n

Phil Pallman\u2019s presentation \u201cA case for interim estimands in adaptive trials\u201d on Thursday morning focused on statistical methodology in adaptive trial designs. Phil\u2019s key message was that analysis objectives using the estimands framework in adaptive design trials should be applied to interim analyses, not just the final analyses.<\/p>\n

\"Kerry
Kerry Hood presenting at ICTMC 2024]<\/figcaption><\/figure>\n

Not forgetting Kerry Hood\u2019s session on \u201cEthical issues and the clinical trials biostatistician\u201d which led to a very interesting discussion and personal examples from the audience on their experiences of such ethical issues in the design and planned analysis of trials.<\/p>\n

Poster Presentations<\/strong><\/h2>\n

Breaks between plenary and parallel sessions allowed attendees to peruse hundreds of skilfully displayed posters. CTR researchers did a fine job of presenting their work in poster format. Their exhibits are described below:<\/p>\n

\"Phil
Phil Markham at ICTMC 2024<\/figcaption><\/figure>\n

Phil Markham presented three posters titled:<\/p>\n

\u201cThe impact and reconciliation of a change in TNM staging classification edition during the Phase III SCOPE2 clinical trial\u201d<\/p>\n

\u201cUtilising repeating (\u2018cloned\u2019) forms to minimise workload required when building, editing or testing clinical trial databases\u201d<\/p>\n

\u201cA specialised REDCap database for PICCOS, a complex randomised CTIMP with a multitude of treatment modalities\u201d<\/p>\n

\"Waku
Waku Maboshe at ICTMC 2024<\/figcaption><\/figure>\n

Waku Maboshe presented two posters on the CLARITY trial:<\/p>\n

\u201cCo-producing drug selection and adaptive design for the CLARITY trial: Investigating clinical and cost-effectiveness of three antithrombotic regimens post-revascularisation in adults with Chronic Limb-Threatening Ischemia\u201d<\/p>\n

\u201cThe adaptive futility analysis design for the CLARITY trial: Investigating clinical and cost-effectiveness of three antithrombotic regimens post-revascularisation in adults with Chronic Limb-Threatening Ischemia\u201d<\/p>\n

Vicky Shepherd presented two posters on her work around improving research involvement pathways for adults lacking capacity:<\/p>\n

\u201cI want the opportunity to be considered\u2019: acceptability and feasibility of implementing advance research planning for trials involving adults lacking capacity to consent\u201d<\/p>\n

\u201cAddressing the knowledge gap: improving inclusion of an under-served group through developing training on trials involving adults with impaired capacity to consent\u201d<\/p>\n

\"Grace
Grace Young at ICTMC 2024<\/figcaption><\/figure>\n

Grace Young presented two posters on SWATs within the PLACEMENT trial:<\/p>\n

\u201cThe PLACEMENT Peer Support SWAT: Evaluating the effects of a peer-to-peer support programme for patients undergoing leg amputation in a surgical CTIMP\u201d<\/p>\n

\u201cPerineural Local Anaesthetic Catheter After Major Lower Limb Amputation Trial (PLACEMENT) Follow-up SWAT: The effect of video information shown prior to discharge on follow-up completion\u201d<\/p>\n

\"Jo
Jo Euden at ICTMC 2024<\/figcaption><\/figure>\n

Jo Euden presented her poster titled \u201cRetention of participants & methods of consent in Emergency Department trials: Lessons from recent experience of the PRONTO trial\u201d. Jo\u2019s poster focused on the qualitative process evaluation findings from the PRONTO trial.<\/p>\n

\"Ben
Ben Karatas and Nina Jacob at ICTMC 2024<\/figcaption><\/figure>\n

Nina Jacob and Ben Karatas presented on the 3P study titled: \u201cThe acceptability of conducting a randomised controlled trial of a parenting program in community sites: Reflections from the 3P Study\u201d<\/p>\n

Helen Stanton presented Sarah Nash\u2019s work on the development of an easy-to-navigate participant database interface titled \u201cThe development of an accessible software platform to accelerate non-commercial trials for rapid patient impact (ASSISTANT)\u201d.<\/p>\n

\"Martina
Martina Svobodova and Nina Jacob at ICTMC 2024<\/figcaption><\/figure>\n

Martina Svobodova presented a poster on \u201cPatient and Public Involvement in the Design and Protocol Development for a Platform Randomised Trial to Evaluate Diagnostic Tests to Optimise Antimicrobial Therapy (PROTECT)\u201d.<\/p>\n

Kat Hollands presented her experiences of collaborative working between the pharmacovigilance team and the trial team with her poster titled \u201cLessons from trials in a region – Experiences from the EWALL-PH-03 trial\u201d.<\/p>\n

Angela Casbard presented a poster on the \u201cApplication of a practical method for eliciting prior beliefs about cancer survival in a phase 3 randomised trial of radiotherapy for skin cancer patients\u201d.<\/p>\n

In collaboration with the UKCRC Data and IS Operations Group (DISOG), Nigel Kirby presented a poster titled \u201cEmpowering Data Managers \u2013 Creating Best Practice Guidelines\u201d.<\/p>\n

Final thoughts<\/strong><\/h2>\n

Finally, reflecting on the ICTMC meeting, the conference showcased an abundance of creativity, featuring everything from a crocheted QR code to a performing arts presentation of mixed methods study results, and even a rap for a lightning talk. Such creativity in science communication makes research accessible, relatable, and memorable. Looking ahead to the 2026 Conference, we encourage everyone to participate and hope for even larger representation from the CTR. Engaging in these events not only allows us to share our work and insights but also to connect with peers and inspire meaningful dialogue within the research community. Could we do more than one workshop, six oral presentations, and sixteen posters? Challenge accepted!<\/p>\n

Hopefully, see you in 2026 for another memorable conference!<\/p>\n","protected":false},"excerpt":{"rendered":"- Helen Stanton, Waku Maboshe and Fiona Lugg-Widger This year, the bi-annual International Clinical Trials Methodology Conference (ICTMC) was held in the beautiful and historic city of Edinburgh, Scotland. Held […]","protected":false},"author":7127,"featured_media":3022,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7],"tags":[],"class_list":["post-3021","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-events"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7dIou-MJ","jetpack-related-posts":[{"id":2396,"url":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/centre-for-trials-research-at-ictmc2022-6th-international-clinical-trials-methodology-conference-ictmc\/","url_meta":{"origin":3021,"position":0},"title":"Centre for Trials Research At #ICTMC2022: 6th International Clinical Trials Methodology Conference (ICTMC)","author":"Cheney Drew","date":"October 27, 2022","format":false,"excerpt":"After a Covid related hiatus, so a year later than planned, the bi-annual International Clinical Trials Methodology Conference (ICTMC) was held in the beautiful spa town of Harrogate at the beginning of October 2022. The ICTMC meeting is a great opportunity to learn about all things methodological in the clinical\u2026","rel":"","context":"In "Events"","block_context":{"text":"Events","link":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/category\/events\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2022\/10\/ICTMC-2022.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2022\/10\/ICTMC-2022.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2022\/10\/ICTMC-2022.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2022\/10\/ICTMC-2022.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2022\/10\/ICTMC-2022.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2022\/10\/ICTMC-2022.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":1645,"url":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/clinical-trials-as-a-catalyst-for-change-in-the-big-easy-the-40th-society-for-clinical-trials-annual-meeting-new-orleans-usa\/","url_meta":{"origin":3021,"position":1},"title":"Clinical Trials As A Catalyst For Change In The \u2018Big Easy\u2019 \u2013 The 40th Society For Clinical Trials Annual Meeting, New Orleans, USA","author":"Victoria Shepherd","date":"June 13, 2019","format":false,"excerpt":"By Victoria Shepherd and Nigel Kirby A taste of New Orleans At times New Orleans felt very much like Wales\u2026\u2026 wet. However, when the sun came out and the puddles dried up New Orleans was a place full of culture and friendly faces. The French Quarter is a vibrant place\u2026","rel":"","context":"In "Events"","block_context":{"text":"Events","link":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/category\/events\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2019\/06\/New-Orleans-SCT.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2019\/06\/New-Orleans-SCT.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2019\/06\/New-Orleans-SCT.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":1676,"url":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/my-asco-centre-for-trials-research-at-the-american-society-of-clinical-oncology-2019\/","url_meta":{"origin":3021,"position":2},"title":"My ASCO: Centre for Trials Research at the American Society of Clinical Oncology 2019","author":"Margherita Carucci","date":"July 25, 2019","format":false,"excerpt":"Background This year I\u2019ve had the great opportunity to attend ASCO (American Society of Clinical Oncology) conference as a Centre for Trials Research representative together with Professor Richard Adams, Director Cancer Division, and Catrin Cox for the presentation of the FAKTION study by the Chief Investigators (CIs), Dr Sacha Howell\u2026","rel":"","context":"In "Cancer Trial"","block_context":{"text":"Cancer Trial","link":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/category\/cancer-trial\/"},"img":{"alt_text":"Centre for Trials Research at ASCO","src":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2019\/07\/IMG-20190604-WA0002.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2019\/07\/IMG-20190604-WA0002.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2019\/07\/IMG-20190604-WA0002.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2019\/07\/IMG-20190604-WA0002.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2019\/07\/IMG-20190604-WA0002.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2019\/07\/IMG-20190604-WA0002.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":1706,"url":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/south-west-research-hub-event-meeting\/","url_meta":{"origin":3021,"position":3},"title":"South West Research Hub Event Meeting","author":"Richard Haggerty","date":"September 5, 2019","format":false,"excerpt":"South West Research Hub event meeting 5th September 2019 The 2nd South West Research Hub meeting was hosted by the Centre for Trials Research on Thursday 5th September 2019 in Cardiff University\u2019s Glamorgan Building. This year\u2019s theme was Trial Methodology. There were around 60 delegates from across the South West\u2026","rel":"","context":"In "Events"","block_context":{"text":"Events","link":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/category\/events\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2019\/09\/SW-Hub-Delegates-2019-scaled.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2019\/09\/SW-Hub-Delegates-2019-scaled.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2019\/09\/SW-Hub-Delegates-2019-scaled.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2019\/09\/SW-Hub-Delegates-2019-scaled.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2019\/09\/SW-Hub-Delegates-2019-scaled.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2019\/09\/SW-Hub-Delegates-2019-scaled.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":2828,"url":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/centre-for-trials-research-at-the-wales-cancer-research-conference-2024\/","url_meta":{"origin":3021,"position":4},"title":"Centre for Trials Research At The Wales Cancer Research Conference 2024","author":"Angela Casbard","date":"March 21, 2024","format":false,"excerpt":"In early March, several Centre for Trials Research (CTR) staff members attended the Wales Cancer Research Conference 2024 at the National Museum, Cardiff. The conference brought together cancer researchers and other stakeholders across Wales and beyond to showcase their research successes and foster new collaborations. Centre for Trials Research Cancer\u2026","rel":"","context":"In "Events"","block_context":{"text":"Events","link":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/category\/events\/"},"img":{"alt_text":"Cancer Division Photo at the Wales Cancer Centre Conference in March 2024.","src":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2024\/03\/WCC1-scaled.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2024\/03\/WCC1-scaled.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2024\/03\/WCC1-scaled.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2024\/03\/WCC1-scaled.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2024\/03\/WCC1-scaled.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2024\/03\/WCC1-scaled.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":1796,"url":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/eu-clinical-trial-regulation-conference\/","url_meta":{"origin":3021,"position":5},"title":"EU Clinical Trial Regulation Conference","author":"Kelly Gee","date":"January 10, 2020","format":false,"excerpt":"Background In early December 2019 I was lucky enough to attend a conference on the EU Clinical Trial Regulation run by the Drug Information Association. Not only did I get to experience the great city of Amsterdam, but I also got to be part of a well delivered and informative\u2026","rel":"","context":"In "Events"","block_context":{"text":"Events","link":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/category\/events\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2020\/01\/Conference-Photo.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2020\/01\/Conference-Photo.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2020\/01\/Conference-Photo.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2020\/01\/Conference-Photo.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2020\/01\/Conference-Photo.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2020\/01\/Conference-Photo.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"meta_box":[],"jetpack_featured_media_url":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2024\/11\/Photo1-CTR.jpg","_links":{"self":[{"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/posts\/3021","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/users\/7127"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/comments?post=3021"}],"version-history":[{"count":1,"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/posts\/3021\/revisions"}],"predecessor-version":[{"id":3038,"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/posts\/3021\/revisions\/3038"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/media\/3022"}],"wp:attachment":[{"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/media?parent=3021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/categories?post=3021"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/tags?post=3021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}